Drugmakers Accused of Favoring Buybacks Over Lower Prices
WSJ What’s News - En podkast av The Wall Street Journal
A.M. Edition for December 7: House Democrats say drugmakers have used savings from tax cuts for things like stock buybacks, instead of for lowering drug prices. The Wall Street Journal's Peter Loftus says the lawmakers have threatened to hold hearings on the matter.
